PSP clinical trial testing new treatments
Treatments studied
Part of Brain & nervous system, Eyes & vision clinical trials.
This trial tests potential new treatments for progressive supranuclear palsy (PSP), a brain disorder affecting movement, balance, and thinking. It aims to see if these treatments are safe and slow the disease. You may be able to join if you have a specific type of PSP and are in fairly good health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with possible or probable PSP Richardson's Syndrome (a specific type) by a doctor.
- Your PSP symptoms started within the last 5 years.
- You can walk at least 10 steps with just a little help (like a hand for balance).
- You have no other major health problems that would make the study unsafe (like heart disease, recent cancer, or serious infections).
- You are not pregnant, breastfeeding, or planning to get pregnant, and you agree to use effective birth control if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at genetic factors in people with PSP, CBS, MSA, or similar brain conditions, and also in their family members. It involves genetic testing to learn more about these diseases and may help find new treatments.
This trial tests a supplement called tributyrin to see if it can help people with progressive supranuclear palsy (PSP), a condition that affects movement and balance. The study is done virtually, so you can participate from home with a caregiver's help.
This study uses brain scans (PET, and possibly spinal fluid) to measure changes linked to “synaptic loss” in people with multiple system atrophy (MSA) or progressive supranuclear palsy (PSP). It may help researchers understand disease changes and how they relate to symptoms, which could guide future treatments.
This study is testing whether digital health tools (like wearable sensors) can better track symptoms of certain brain conditions (PSP, DLB, and MCI with Lewy bodies). It aims to improve monitoring and care for people with these conditions.
This trial tests a new medicine called NIO752 for people with progressive supranuclear palsy (PSP), a condition that affects movement, balance, and thinking. The goal is to see if it can help slow the disease's progression.
This trial tests a drug called LM11A-31 to see if it can help people with progressive supranuclear palsy (PSP), a rare brain condition. You may join if you have had symptoms for 5 years or less, can walk with minimal help, and have good thinking abilities.
Hear when a new Progressive Supranuclear Palsy(PSP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.